How to Turn $100,000 Into $1 Million in 25 Years
The process isn’t hard; it’s the discipline that will require a big commitment.
BIS2022 – Artificial Intelligence: Enabling Humans To Become Superhuman
BIS2022 features in-depth presentations from ARK’s research team and seeks to educate attendees on the impact of breakthrough technologies…
3 Social Security Myths That Could Throw a Wrench Into Your Retirement
Don’t let these myths wreck your retirement plans.
These 2 Renewable Energy Stocks Are Too Cheap to Ignore
These renewable energy dividend stocks could be headed for big things.
Retirees in These 13 States Risk Losing Some of Their Social Security Checks
Will you wind up with a smaller benefit due to where you live?
BIS2022 – Disruptive Innovation: Change and Convergence
BIS2022 features in-depth presentations from ARK’s research team and seeks to educate attendees on the impact of breakthrough technologies…
March 4, 2022 — In The Know with Cathie Wood
On episode XXVI of In the Know, ARK CEO/CIO, Cathie Wood, weighs in on inflation, interest rates, Russia-Ukraine, and how innovation solves…
New discovery may help reduce side effects of multiple sclerosis drugs
Investigators have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.
Scientists identify areas of high marine mammal diversity
Sightings of more than 1 million marine mammals in the federally protected Northeast Canyons and Seamounts Marine National Monument and sites along the Atlantic Coast have been used to identify areas of high marine mammal diversity. These findings unde…
Possible common thread between many neurodegenerative diseases
Researchers reveal a new fibril in diseased brains, one formed by a protein normally busy cleaning cells.
Event horizons are tunable factories of quantum entanglement
Physicists have leveraged quantum information theory techniques to reveal a mechanism for amplifying, or ‘stimulating,’ the production of entanglement in the Hawking effect in a controlled manner. Furthermore, these scientists propose a protocol for te…
Meddling with metals: Escaping the tyranny of copper
Researchers have reported a new protein-design strategy to sidestep the Irving-Williams Series, allowing proteins to behind to other metals ahead of copper.
Why Affirm Holdings Plummeted 34.7% in February
The “buy now, pay later” company continues to struggle.
Why Shares of MP Materials Rose 14% in February
A flurry of catalysts helped to propel this mining stock higher last month.
Before the Miniseries: Rebecca Jarvis on Understanding Elizabeth Holmes
Based on the hit podcast of the same name, “The Dropout” is a new miniseries starting March 3 on Hulu.
Why Kroger Stock Was Up More Than 25% This Week
Investors sniffed a bargain after the grocer’s strong quarter.
Snowflake Stock Is Down Nearly 50% From its Highs. Is it a Buy Now?
Could this be the profit opportunity you’ve been waiting for?
Single test for over 50 genetic diseases will cut diagnosis from decades to days
A single DNA test has been developed that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies and fragile X syndrome. The new test avoids a ‘diagnostic odyssey’ fo…
Visualizing the invisible: New fluorescent DNA label reveals nanoscopic cancer features
Researchers have developed a new fluorescent label that gives a clearer picture of how DNA architecture is disrupted in cancer cells. The findings could improve cancer diagnoses for patients and classification of future cancer risk.
Why Novavax Stock Is Sliding Today
Investors aren’t convinced the biotech has a solid, long-term outlook.